Fundraising Fox

Endostim

St. Louis, US · Founded 2009 · Delaware corporation · 4 employees on LinkedIn · 1 known investors

EndoStim develops a neurostimulation medical device system for treating drug-resistant gastroesophageal reflux disease (GERD) by restoring esophageal function while preserving normal anatomy.

BiotechHealthtechMedical Devices

Founders & leadership

EGEric Goorno
Eric GoornoChief Executive Officer
GWGreg Wilson
Greg WilsonChief Financial Officer
SAStephen Attwood, MD
Stephen Attwood, MDSurgical Director
VSVirender Sharma, MD
Virender Sharma, MDChief Medical Officer
HAHazim Ansari
Hazim AnsariChief Legal Counsel
BJ
Bevil J. HoggExecutive
PG
Paul GoodeExecutive
PS
Peggy S. StohrExecutive
VK
Virender K. SharmaNamed on SEC filing
SP
Shai PolickerNamed on SEC filing

Board

DD
Douglas D. FrenchBoard director
JM
Jeffrey M. McDonnellBoard director

Investors · 1

Relevance VenturesBrentwood · $250K – $2.5M

Reported raises · per SEC filings

Form D private placements

$34.9M disclosed across 5 rounds · 2014–2018

▶$2.8MraisedDec 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian FarleyDirector
  • Paul V. GoodeExecutive Officer
  • Alexander SchmitzDirector
  • Virender K. SharmaExecutive Officer
  • Douglas D. FrenchDirector
Offering amount
$7M
Amount sold
$2.8M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.1MraisedJan 2018 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rohan J. HoareExecutive Officer, Director
  • Douglas D. FrenchDirector
  • Kimberly PinsonExecutive Officer
  • Alexander SchmitzDirector
  • Paul GoodeExecutive Officer
  • Virender K. SharmaExecutive Officer
Offering amount
$25M
Amount sold
$12.1M
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.1MraisedMar 2016 · 83 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander SchmitzDirector
  • Paul GoodeExecutive Officer
  • Peggy S. StohrExecutive Officer
  • Shai PolickerExecutive Officer
  • Douglas D. FrenchDirector
  • Bevil J. HoggExecutive Officer, Director
Offering amount
$20M
Amount sold
$11.1M
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedMay 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bevil J. HoggExecutive Officer, Director
  • Paul GoodeExecutive Officer
  • Peggy S. StohrExecutive Officer
  • Raul E. PerezDirector
  • Douglas D. FrenchDirector
  • Virender K. SharmaDirector
  • Ralph G. DaceyDirector
  • Jeffrey M. McDonnellDirector
  • Shai PolickerExecutive Officer
  • Fred C. GoadDirector
Offering amount
$5M
Amount sold
$2.5M
Minimum investment
$2.5M
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.4MraisedJul 2014 · 72 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peggy S. StohrExecutive Officer
  • Raul E. PerezDirector
  • Virender K. SharmaDirector
  • Douglas D. FrenchDirector
  • Jeffrey M. McDonnellDirector
  • Ralph G. DaceyDirector
  • Shai PolickerExecutive Officer
  • Paul GoodeExecutive Officer
  • Fred C. GoadDirector
  • Bevil J. HoggExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$6.4M
Sales commissions
$100K
Placement agents
Stifel, Nicolaus & Company, Incorporated, Healthios Capital Markets, LLC
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Medscape3 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Osmosis3 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies competing with Endostim for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

EndoStim raises $25m Series D for neurostim GERD device - MassDevicemassdevice.com · May 2016

Frequently asked questions

What does Endostim do?
EndoStim develops a neurostimulation medical device system for treating drug-resistant gastroesophageal reflux disease (GERD) by restoring esophageal function while preserving normal anatomy.
Who are Endostim's investors?
Endostim's investors include Relevance Ventures.
How much funding has Endostim raised?
Endostim has disclosed $34.9M raised across 5 rounds.
Where is Endostim headquartered?
Endostim is headquartered in St. Louis, US.